Research programme: toll-like receptor 4 modulators - GlaxoSmithKline
Alternative Names: CRX 527; TLR 4 modulators - GlaxoSmithKline; Toll-like receptor 4 modulators research programme - GlaxoSmithKlineLatest Information Update: 25 May 2007
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Toll-like receptor 4 modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Immunological disorders
Most Recent Events
- 09 Sep 2003 Preclinical trials in Immunological disorders in USA (unspecified route)